Zydus Lifesciences submits press release

28 Feb 2026 Evaluate

Zydus Lifesciences has submitted a press release stating that Zydus receives final approvals from USFDA for Ivermectin Tablets USP, 3 mg and Dapsone Tablets USP, 25 mg and 100 mg.

The above information is a part of company’s filings submitted to BSE.


Zydus Lifesciences Share Price

904.10 -8.85 (-0.97%)
09-Mar-2026 13:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1810.35
Dr. Reddys Lab 1285.90
Cipla 1319.75
Zydus Lifesciences 904.10
Lupin 2293.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×